CVS Health Corporate — Revenue decreased by 5.0% to $100.43B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.2%, from $94.59B to $100.43B. Over 4 years (FY 2021 to FY 2025), Corporate — Revenue shows an upward trend with a 8.3% CAGR.
An increase may indicate higher inter-company service fees or non-core income, while a decrease often reflects changes in accounting eliminations or reduced non-operating revenue.
This metric captures the total revenue recognized by the corporate segment, which generally includes income from central...
Most large conglomerates report similar 'Corporate' revenue lines, which are often minimal or negative due to the elimination of inter-segment transactions.
cvs_segment_corporate_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $72.62B | $73.79B | $76.60B | $76.83B | $80.64B | $81.16B | $83.85B | $85.28B | $88.92B | $89.76B | $93.81B | $88.44B | $91.23B | $95.43B | $97.71B | $94.59B | $98.92B | $102.87B | $105.69B | $100.43B |
| QoQ Change | — | +1.6% | +3.8% | +0.3% | +5.0% | +0.6% | +3.3% | +1.7% | +4.3% | +0.9% | +4.5% | -5.7% | +3.2% | +4.6% | +2.4% | -3.2% | +4.6% | +4.0% | +2.7% | -5.0% |
| YoY Change | — | — | — | — | +11.0% | +10.0% | +9.5% | +11.0% | +10.3% | +10.6% | +11.9% | +3.7% | +2.6% | +6.3% | +4.2% | +7.0% | +8.4% | +7.8% | +8.2% | +6.2% |